公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240 | Vogel, Arndt; Merle, Philippe; Verslype, Chris; Finn, Richard S; Zhu, Andrew X; ANN-LII CHENG ; Chan, Stephen Lam; Yau, Thomas; Ryoo, Baek-Yeol; Knox, Jennifer; Daniele, Bruno; Qin, Shukui; Wei, Ziwen; Miteva, Yanna; Malhotra, Usha; Siegel, Abby B; Kudo, Masatoshi | Therapeutic advances in medical oncology | 7 | 6 | |
2024 | Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study | Piscaglia, Fabio; Ikeda, Kenji; ANN-LII CHENG ; Kudo, Masatoshi; Ikeda, Masafumi; Breder, Valery; Ryoo, Baek-Yeol; Mody, Kalgi; Ren, Min; Ramji, Zahra; Sung, Max W | Cancer | 1 | | |
2022 | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial | Kelley, Robin Kate; Rimassa, Lorenza; ANN-LII CHENG ; Kaseb, Ahmed; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Banerjee, Kamalika; Hazra, Saswati; Fawcett, Jonathan; Yau, Thomas | The Lancet. Oncology | 210 | 185 | |
2024 | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study | Yau, Thomas; Kaseb, Ahmed; ANN-LII CHENG ; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Milwee, Steven; Wang, Zhong; Curran, Dominic; Kelley, Robin Kate; Rimassa, Lorenza | The lancet. Gastroenterology & hepatology | 3 | | |
2015 | Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials. | Meyer, Tim; Palmer, Daniel H.; Chao, Yee; Choi, Caren; Deptala, Andrzej; Fartoux, Laetitia; Feng, Yin-Hsun; Graham, Janet Shirley; Hocke, Julia; Kim, Tae-You; Lin, Deng-Yn; Ma, Yuk Ting; Peck-Radosavljevic, Markus; Ross, Paul J.; Ryoo, Baek-Yeol; Wenz, Arne; Yen, Chia-Jui; Loembe, Arsene-Bienvenu; Cheng, Ann-Lii | J. Clin. Oncol. | | | |
2015 | Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials. | Meyer, Tim; Palmer, Daniel H.; Chao, Yee; Choi, Caren; Deptala, Andrzej; Fartoux, Laetitia; Feng, Yin-Hsun; Graham, Janet Shirley; Hocke, Julia; Kim, Tae-You; Lin, Deng-Yn; Ma, Yuk Ting; Peck-Radosavljevic, Markus; Ross, Paul J.; Ryoo, Baek-Yeol; Wenz, Arne; Yen, Chia-Jui; Loembe, Arsene-Bienvenu; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
2023 | Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial | Llovet, Josep M; Kudo, Masatoshi; Merle, Philippe; Meyer, Tim; Qin, Shukui; Ikeda, Masafumi; Xu, Ruocai; Edeline, Julien; Ryoo, Baek-Yeol; Ren, Zhenggang; Masi, Gianluca; Kwiatkowski, Mariusz; Lim, Ho Yeong; Kim, Jee Hyun; Breder, Valeriy; Kumada, Hiromitsu; ANN-LII CHENG ; Galle, Peter R; Kaneko, Shuichi; Wang, Anran; Mody, Kalgi; Dutcus, Corina; Dubrovsky, Leonid; Siegel, Abby B; Finn, Richard S | The Lancet. Oncology | 11 | | |
2022 | Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma | Rimassa, Lorenza; Kelley, Robin Kate; Meyer, Tim; Ryoo, Baek-Yeol; Merle, Philippe; Park, Joong-Won; Blanc, Jean-Frederic; Lim, Ho Yeong; Tran, Albert; Chan, Yi-Wah; McAdam, Paul; Wang, Evelyn; ANN-LII CHENG ; El-Khoueiry, Anthony B; Abou-Alfa, Ghassan K | Liver cancer | 15 | 14 | |
2023 | Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE) | Ryu, Min-Hee; Lee, Kyung Hee; Shen, Lin; KUN-HUEI YEH ; Yoo, Changhoon; Hong, Young Seon; Park, Young Iee; Yang, Sung Hyun; Shin, Dong Bok; Zang, Dae Young; Kang, Won Ki; Chung, Ik-Joo; Kim, Yeul Hong; Ryoo, Baek-Yeol; Nam, Byung-Ho; Park, Young Soo; Kang, Yoon-Koo | Cancer medicine | 3 | 1 | |